Moving from PF-ILD to PPF

Overview

Journal Lung India

Specialty Pulmonary Medicine

Date 2023 Jul 7

PMID 37417080

Authors

Parthasarathi Bhattacharyya

Affiliations

Soon will be listed here.

References

Cottin V, Wollin L, Fischer A, Quaresma M, Stowasser S, Harari S . Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev. 2019; 28(151). PMC: 9489101. DOI: 10.1183/16000617.0100-2018. View

Collard H, Ryerson C, Corte T, Jenkins G, Kondoh Y, Lederer D . Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016; 194(3):265-75. DOI: 10.1164/rccm.201604-0801CI. View

Martinez F, Collard H, Pardo A, Raghu G, Richeldi L, Selman M . Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017; 3:17074. DOI: 10.1038/nrdp.2017.74. View

Nathan S, Albera C, Bradford W, Costabel U, du Bois R, Fagan E . Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis. Thorax. 2016; 71(5):429-35. PMC: 4862066. DOI: 10.1136/thoraxjnl-2015-207011. View

Schmidt S, Tayob N, Han M, Zappala C, Kervitsky D, Murray S . Predicting pulmonary fibrosis disease course from past trends in pulmonary function. Chest. 2013; 145(3):579-585. PMC: 3941249. DOI: 10.1378/chest.13-0844. View

Paterniti M, Bi Y, Rekic D, Wang Y, Karimi-Shah B, Chowdhury B . Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2017; 14(9):1395-1402. DOI: 10.1513/AnnalsATS.201606-458OC. View

Raghu G, Remy-Jardin M, Myers J, Richeldi L, Ryerson C, Lederer D . Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018; 198(5):e44-e68. DOI: 10.1164/rccm.201807-1255ST. View

du Bois R, Weycker D, Albera C, Bradford W, Costabel U, Kartashov A . Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med. 2011; 184(12):1382-9. DOI: 10.1164/rccm.201105-0840OC. View

Papadopoulos C, Pitsiou G, Karamitsos T, Karvounis H, Kontakiotis T, Giannakoulas G . Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic [corrected] study. Eur Respir J. 2007; 31(4):701-6. DOI: 10.1183/09031936.00102107. View

10.

Raghu G, Remy-Jardin M, Richeldi L, Thomson C, Inoue Y, Johkoh T . Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022; 205(9):e18-e47. PMC: 9851481. DOI: 10.1164/rccm.202202-0399ST. View

11.

Natsuizaka M, Chiba H, Kuronuma K, Otsuka M, Kudo K, Mori M . Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med. 2014; 190(7):773-9. DOI: 10.1164/rccm.201403-0566OC. View

12.

Lizak M, Zakliczynski M, Jarosz A, Zembala M . The influence of chronic heart failure on pulmonary function tests in patients undergoing orthotopic heart transplantation. Transplant Proc. 2009; 41(8):3194-7. DOI: 10.1016/j.transproceed.2009.07.072. View